April 12, 2013

North Carolina Justice Center: Profiles in corporate tax avoidance- Merck

ITEP Work in Action
Merck & Co. at a glance
One of the largest pharmaceutical companies in the world; key player in global vaccine production and distribution.
2012 Sales: $14 billion
2012 Assets: Total assets of the Merck Group—$28.3 billion
Total Profits 2008-12: $19.6 billion
Profits held offshore: $53.4 billion as of 2012 ($22.2 billion added betweem 2008 and 2012.)
Effective tax rate on total profits earned 2008-2012 (including those sheltered offshore: 8.6% (18.4% when sheltered profits are excluded.)

Read the Full Report